Pharmaceuticals

Strong CAGR to Propel in the Animal Model Market and Beyond upto $2.92 Billion by 2029

June 4, 2025 by The Business Research Company

Discover trends, market shifts, and competitive outlooks for the animal model industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Animal Model Market, and What Factors Will Drive It?#_x000D_

The market for animal models has seen robust expansion in recent years. A rise from $1.92 billion in 2024 to $2.09 billion in 2025, with a compound annual growth rate (CAGR) of 9.0% is expected. Factors contributing to this growth during the historic period include a surge in using animal models for biomedical research, increasing expenditure and heavy investments in drug discovery and development, an amplified emphasis on precision medicine, and a broad range of applications of animal models in the healthcare sector._x000D_

_x000D_

In the coming years, a significant escalation is expected in the animal model market, which is projected to reach a valuation of $2.92 billion by 2029, growing at an 8.8% Compound Annual Growth Rate (CAGR). Factors such as the enhancement in genetic engineering, the rise of personalized medicine, the escalating incidence of chronic diseases, an increasing requirement for competent vaccines and treatments, and an increase in investment for biomedical research are credited for the predicted growth during this forecast period. Major trends during this period include the increasing demand for animal models in the fields of drug discovery and development, rising chronic disease prevalence, the physiological similarities between humans and animals expediting drug development time, a surge in personalized medicine consumption heightening the demand for humanized mice models, and high market growth due to the increasing adoption of animal models for performing biomedical research._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Animal Model Market?#_x000D_

The expansion of the animal model market is expected to be fueled by escalating investments in pharmaceutical research and development. This form of research and development is a sophisticated combination of science and innovation that leads to new medical breakthroughs. The development of innovative therapies and the quest for treatments for complex diseases, alongside the promotion of scientific intrigue and commercial opportunities in the healthcare sector, advances this research and development process. Animal models prove crucial in pharmaceutical research and development as they help predict the effectiveness, safety and toxicity of drugs. They also offer understanding into biological operations and assist in creating new treatments by emulating human physiological responses to disease progression in regulated environments. For instance, the European Federation of Pharmaceutical Industries and Associations, a trade association and lobbying organization based in Belgium, recorded that pharmaceutical research and development expenditures in Europe rose to €44,500 million ($47,999 million) in 2022, up from €42,533 million ($45,877 million) in 2021. As such, the escalating investment in pharmaceutical research and development is propelling the animal model market._x000D_

_x000D_

#Which Primary Segments of the Animal Model Market Are Driving Growth and Industry Transformations?#_x000D_

The animal model market covered in this report is segmented –_x000D_

_x000D_

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types_x000D_

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies_x000D_

3) By Application: Drug Discovery And Development, Basic Research, Other Applications_x000D_

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations_x000D_

_x000D_

Subsegments:_x000D_

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice_x000D_

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats_x000D_

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs_x000D_

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds_x000D_

5) By Hamsters: Syrian Hamsters, Chinese Hamsters_x000D_

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the Animal Model Market?#_x000D_

North America was the largest region in the animal model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering the Animal Model Market Direction?#_x000D_

Key businesses in the animal model market are concentrating their efforts on the creation of innovative products, such as triple-immunodeficient animal models, with the aim of improving the precision and trustworthiness of preclinical studies, aiding sophisticated biomedical experiments, and expediting the creation of new treatments for severe human illnesses. Animals, primarily mice, that are lacking in three crucial immune system components are specifically test-fabricated for these triple-immunodeficient animal models. These models have proved paramount in biomedical research, especially for studying human diseases and designing novel treatments. For example, Charles River Laboratories International, Inc., a pharmaceutical company based in the US, introduced NCG mouse strains in January 2024. These strains act as a triple-immunodeficient mouse model intended for oncology research. NCG mice are devoid of functional or mature T, B, and NK cells, and have diminished macrophage and dendritic cell functions. They are capable of carrying xenograft cells, tissues, and elements of the human immune framework. This mouse model is perfect for research in spheres such as oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplantations. NCG mice can also be utilized to generate humanized mice by grafting PBMCs or CD34+ stem cells, therefore emulating the human immune mechanism closely._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Animal Model Market?#_x000D_

An animal model is a non-human species used in scientific research to understand biological processes, study disease mechanisms, and evaluate the efficacy and safety of new treatments and interventions. These models allow researchers to advance medical knowledge and develop new therapies, bridging the gap between basic research and clinical application._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15510_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_